Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a complex and refractory malignant tumor, ranking the third cause of cancer-related deaths worldwide. Lenvatinib is currently employed to treat advanced, unresectable HCC as a first-line drug. The purpose of this study was to explore the pharmacological mechanisms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Han, Bing, Zhang, Yanxia, Wang, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205703/
https://www.ncbi.nlm.nih.gov/pubmed/35720901
http://dx.doi.org/10.1155/2022/7102500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205703/
https://www.ncbi.nlm.nih.gov/pubmed/35720901
http://dx.doi.org/10.1155/2022/7102500

Ejemplares similares